Wie hoch ist der Preis für Kexing Biopharm Co., Ltd. (688136)

Preis für Kexing Biopharm Co., Ltd. (688136) ist $3.13

Wie hoch ist die Marktkapitalisierung für Kexing Biopharm Co., Ltd. (688136)

Marktkapitalisierung für Kexing Biopharm Co., Ltd. (688136) ist $621.33M

Kexing Biopharm Co., Ltd. (688136) Preis und Marktkapitalisierung

Kexing Biopharm Co., Ltd. is a global pharmaceutical enterprise primarily involved in the exploration, manufacturing, and commercialization of advanced recombinant protein-based drugs and microbial preparations, serving both the Chinese domestic market and international clientele. The company strategically directs its research and development endeavors towards crucial medical areas, specifically focusing on antiviral therapies, oncology, immunology, hematological conditions, digestive system health, and degenerative diseases. Its extensive product lineup features diverse pharmaceutical solutions. This includes innovative recombinant human proteins such as interferon a1b, erythropoietin, and granulocyte stimulating factor. Additionally, their offerings encompass microbial formulations like Clostridium butyricum combined live bacteria powder, traditional Chinese patent medicines (e.g., Kehuang Capsule), and chemical drugs like Entecavir. Kexing Biopharm also provides cutting-edge biologics, including liraglutide (a human glucagon-like peptide-1), along with other specialized therapeutics such as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab, neratinib maleate tablets, and lenalidomide capsules. Established in 1989, the company's main operations are situated in Jinan, China.

Preis für 688136	Vermögenswert B	Marktkapitalisierung von B	Ergebnisse
$26,506.21 $621.33M	NVDA	$5.264T	+847,098.02%
$23,673.28 $621.33M	AAPL	$4.701T	+756,551.17%
$21,034.18 $621.33M	GOOG	$4.177T	+672,199.70%
$19,222.52 $621.33M	MSFT	$3.817T	+614,295.12%
$14,433.44 $621.33M	AMZN	$2.866T	+461,225.22%

Preis für 688136

Vermögenswert B

Marktkapitalisierung von B

Ergebnisse

$26,506.21 $621.33M